周五盘中，港股创新药概念股延续强势，歌礼制药-B（01672.HK）表现亮眼，股价大涨7.49%，引发市场关注。
数据显示，除歌礼制药-B外，其他创新药概念股也呈现出强劲涨势。晶泰控股（02228.HK）涨幅接近10%，先声药业（02096.HK）和中国生物制药（01177.HK）均上涨超过5%。这一现象反映出投资者对创新药行业前景持续看好。
分析人士指出，创新药企业的股价走强可能与行业政策支持、研发进展以及市场需求增长等因素有关。虽然目前没有针对歌礼制药-B的具体利好消息，但整体行业趋势积极，带动了该公司股价的上涨。投资者应密切关注该公司未来的研发进展和业绩表现。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.